Summary Following up-regulation of an angiogenesis inhibitor by the wild-type p53 protein proven recently, we have analysed on the one hand the prognostic impact of microvessel count (MC) and p53 protein overexpression in non-small-cell lung carcinoma (NSCLC) progression and, on the other hand, the inter-relation between the microvascular pattern and the p53 protein expression. Moreover, we assessed the expression of vascular endothelial growth factor (VEGF), one of the pivotal mediators of tumour angiogenesis, in order to investigate its relation to p53 protein expression and MC. Tumours from 73 patients resected for NSCLC between March 1991 and April 1992 (median follow-up 47 months, range 32-51 months) were analysed using an immunohistochemical method. In univaiiate analysis, MC and p53 accumulation were shown to affect metastatic nodal involvement, recurrence and death significantly. Multiple logistic regression analysis showed an important prognostic influence of MC and nodal status on overall (P = 0.0009; P = 0.01) and disease-free survival (P = 0.0001; P = 0.03). Interestingly, a strong statistical association was observed between p53 nuclear accumulation and MC (P = 0.0003). The same inter-relationship was found in non-squamous histotype (P = 0.002). When we analysed the concomitant influence of MC and p53 expression on overall survival, we were able to confirm a real predominant role of MC in comparison with p53. With regard to VEGF expression, p53-negative and lowly vascularized tumours showed a mean VEGF expression significantly lower than p53-positive and highly vascularized cancers (P = 0.02). These results underline the prognostic impact of MC and p53 protein accumulation in NSCLC and their reciprocal interrelationship, supporting the hypothesis of a wild-type p53 regulation on the angiogenetic process through a VEGF up-regulation.
The most important steps in the evaluation of human cancers include diagnosis and prognosis. Prognostic evaluation represents a critical step involving a therapeutic approach. In the last two decades, major efforts have been directed towards a biological characterization of human solid cancers, and interesting results have been obtained in this field (Harris and Hollstein, 1993) . Some biological parameters have been shown to have an important role in both the development and the progression of several types of human cancer. Non-small-cell lung carcinoma is a lung cancer subgroup of particular interest for its heterogeneity in terms of both histopathological classification and behaviour. Up until now, NSCLC prognosis has been strongly influenced by clinicopathological parameters (i.e. performance status, tumour status, nodal metastatic involvement and distant metastasis), although several recent studies have demonstrated a putative prognostic role of biological factors for this group of cancers (Slebos et al, 1991; Tateishi et al, 1991; Fontanini et al, 1992) . In particular, some protein products, such as p53 protein, are directly involved in the cancerization mechanism, malignant transformation and progression, and the angiogenetic pattern with regard to the number of microvessels has been shown to influence considerably the prediction of recurrence and death in these types of cancer (Quinlan et al, 1992 ; Macchiarini et al, 1992) .
Recent experimental evidence in cultured fibroblasts from Li-Fraumeni patients has underlined that the switch to the angiogenic phenotype coincides with loss of the wild-type p53 tumoursuppressor gene with consequent reduced expression of some angiogenic inhibitors, such as thrombospondin-l (Dameron et al, 1994) .
Since tissue p53 protein expression results from gene alterations, we analysed on the one hand the prognostic influence of p53 accumulation and microvessel count in a series of NSCLCs and on the other hand their mutual relation as a basis for studying the putative regulation of angiogenesis by the p53 gene in the epithelial tissue as well.
The supposed induction of the VEGF expression through the protein kinase C pathway stimulation in the presence ofp53 tumoursuppressor gene mutation (Kieser et al, 1994) (Mountain, 1986) and the World Health Organization Histological Classification (World Health Organization, 1982 The prognostic impact of p53-regulated angiogenesis 1297 Microvascular count
The area of most intense vascular count was identified for each tumour sample (Figure 3 ) and the median value of this series (15 vessels per 250 x power field) allowed us to separate tumours with high from tumours with low MC. Tables 1 and 2 show that tumours with metastatic nodal involvement and/or which relapsed during follow-up had a higher number of microvessels compared with cancers with no metastatic involvement (P = 0.002; P = 0.0001). In addition, shorter relapse-free and overall survival were observed in patients with high microvessel count in their tumours ( Figure 4A : P = 0.00003; Figure 4B : P = 0.00001). Multiple logistic regression analyses reported in Tables 3 and 4 underlined the strong prognostic influence of MC and nodal status on overall (P = 0.0009; P = 0.01) and relapse-free survival (P = 0.0001; P = 0.03). The prognostic impact of MC was further confirmed when we analysed the concurrent influence of MC and p53 expression on overall survival. As reported in Figure 5 , a significant statistical difference in overall survival was observed between patients whose tumours showed alternatively low MC and low p53, low MC and high p53, high MC p53 Figure 7 Relation between MC and p53 protein in 28 cases of nonsquamous subgroup of NSCLC (linear regression r= 0.58; P= 0.001) and low p53 (condensed below 'All cases except MC > 15p53 > 20') compared with patients whose tumours showed both high MC and high p53 (P = 0.001).
Relation between p53 expression and microvessel count Interestingly, when MC was compared with p53 nuclear accumulation, a strong statistical association was found between these two variables (linear regression: r = 0.41; P = 0.0003) (Figure 6 ). In fact, mean p53 immunoreactivity was significantly more intense (41.1 ± 31) in tumours with high MC than in those with low MC (19.7 ± 22) (P = 0.01), as reported in Table 5 . Given the fact that the non-squamous histotype had a higher MC than squamous cell carcinomas, it was interesting to check any correlation between MC and p53 positivity even in the case of histological types. A British Journal of Cancer (1997) 75(9) 
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The prognostic impact of p53-regulated angiogenesis 1299 strong statistical association was found between p53 and MC in nonsquamous subtypes as reported in Figure 7 (r = 0.58; P = 0.001).
VEGF expression according to MC and p53
VEGF immunoreactivity was detected in the cytoplasm of neoplastic cells with particular accumulation in the perinuclear area ( Figure 8 ) and 63 out of 66 of the tumours (95.4%) expressed VEGF protein (mean 37.1 + 22; range 5-80%). The median value (40) of the whole series was assumed as the cut-off value to distinguish tumours with low from tumours with high VEGF expression. A significant statistical association was found between VEGF expression and both MC and p53 immunoreactivity. As shown in Table 6 , the p53-positive and highly vascularized tumours (MC > 15 vessels per 250 x field) showed a significantly higher VEGF protein expression (P = 0.02; P = 0.02). The same statistical association was maintained comparing VEGF expression in tumours with low or high p53 according to the median value of p53 (< vs > 20% of positive cells) (P = 0.04) ( Table 6 ).
DISCUSSION
In this study, we took into account the role of MC and p53 protein expression in the progression of one of the most frequent and aggressive types of epithelial human cancer, non-small-cell lung carcinoma. Our results have focused on two main aspects: the prognostic impact of MC and p53 expression and the inter-relation between these two factors.
MC and prognosis
The prognostic role of MC has been widely reported in several types of solid human cancer, such as mammary (Weidner et al, 1991) , head and neck (Gasparini et al, 1993) , prostate , ovarian (Hollingsworth et al, 1995) , colorectal (Saclarides et al, 1994) , testicular (Olivarez et al, 1994) , urotelial (Uaeger et al, 1994) , cutaneous (Barnhill et al, 1992) , nervous (Li et al, 1994) and bronchial carcinomas Yamasaki et al, 1994; Fontanini et al, 1995a) . These studies, mostly in breast cancers, have shown that intra-tumour microvessel count has an independent prognostic significance when compared with traditional prognostic markers in multivariate analysis (Gasparini and Figure 8 Cytoplasmic VEGF expression in well-differentiated adenocarcinoma of the lung (ABC method; 25 x) Harris, 1995) . In our study, an increasing intra-tumour microvessel count with greater incidence of metastases and/or decreased patient survival has been observed, confirming both ours and other previous data in lung cancer and in other types of solid neoplasms Yamasaki et al, 1994; Fontanini et al, 1995b; Weidner and Folkman, 1996) . The formation of new capillaries makes it possible for the tumour cells to gain secondary sites successfully and to develop metastases. For this reason, the microvascular bed represents an important requirement for the growth and metastatic spread of primary tumours and also the biological foundation of the prognostic potential of MC.
p53 expression and prognosis
Alterations of the p53 gene with consequent nuclear overexpression have been observed in several human cancers, including NSCLC (Lane, 1990) , underlining the important role of p53 modifications in tumour development. These alterations seem to be an early event during bronchial cancer progression as demonstrated by several authors who have reported a p53 accumulation in preinvasive lesions of the bronchial tree (Sozzi et al, 1992; Sundaresan et al, 1992; Bennett et al, 1993; Fontanini et al, 1994) . However, some experimental evidence has also shown an association between shorter survival and p53 protein expression (Quinlan et al, 1992; Fontanini et al, 1995a) , although further information will obviously be necessary before this parameter can be used in the prognostic evaluation of human cancers. Indeed, the putative prognostic role of the p53 also observed in this series contrasts with recent results by Lee et al (1995) p53 expression and MC In our study, p53 tumour expression and MC were compared for the analysis of their reciprocal inter-relation. Tumours with high MC both in the entire series and in the non-squamous subgroup presented an increasing p53 expression, suggesting a putative influence of this tumour-suppressor gene on the development of the angiogenic pattern. Recent experimental evidence suggests that new vessel formation in tumours as well as in cultured cell lines is under tumour-suppressor gene control. In a cultured BHK fibroblast cell line converted to anchorage independence and tumorigenicity by loss of a tumour-suppressor gene, Rastinejed et al (1989) have shown that suppressor loss is accompanied by a gain in their ability to acquire the angiogenic phenotype. Moreover, in a glioblastoma cell line that does not express the p53 protein because of an internal rearrangement of the gene and that causes tumours with glioblastoma histology, Van Meier et al (1994) have underlined a down-regulation of angiogenetic capability following introduction of a tetracycline-regulated wild-type p53 gene into the cells. Concomitantly, in the fibroblast of patients with Li-Fraumeni syndrome, Dameron et al (1995) have demonstrated that the loss of the wild-type p53 is followed by a downregulation of a potent inhibitor of angiogenesis.
MC, p53 and VEGF expression
This is the first study in which the relation between MC, p53 and VEGF expressions has been investigated in human lung carcinoma. Recently, Mattern et al (1996) analysed a series of 91 epidermoid lung carcinomas and, apart from the different percentage of cancers expressing the VEGF protein, they found a statistical association between the MC and VEGF expression. They did not analyse the relation between p53 and VEGF, which appears to be strictly connected in the regulation of tumour angiogenesis. Recently, some data have been achieved concerning the influence of wild-type p53 on the human VEGF expression by Mukhopadhyay et al (1995) , who demonstrated a pronounced suppressive effect of the VEGF gene expression on an adenovirustransformed human fetal kidney cell line. On the other hand, a mutant form of p53 has been shown to be implicated in the 12-0-tetradecanoylphorbol-13-acetate induction of the VEGF gene expression mediated by the protein kinase C (Kieser et al, 1994) . The association between VEGF, MC and p53 underlines on the one hand the important role of VEGF in the control of neoangiogenesis in NSCLC, and on the other hand the hypothesis that the wild-type p53 protein may stop cell cancer development by attracting newly formed vessels.
On the basis of the in vitro and in vivo evidence, we believe that a more detailed analysis of angiogenic growth factors and inhibitor expression in human tumour samples will provide useful information about the genetic control of the angiogenic phenomenon in cancer. ABBREVIATIONS MC, microvessel count; VEGF, vascular endothelial growth factor; NSCLC, non-small-cell lung cancer; OS, overall survival; RFS, relapse-free survival.
